Search

everythinglearnresearchcommunity

for

Search:↓

Birth control pills increase certain receptor activities in female gerbil prostate glands and can lead to prostate changes.

The study's results on the effectiveness of low-dose IL-2 for alopecia areata and its impact on immune cells were not provided.

All treatments reduce hair growth; low dose flutamide most effective with fewer side effects.

The new gel formula could improve the delivery of a hair loss treatment through the skin and might be an alternative to taking it by mouth.

Liraglutide caused significant weight loss in some obese women with PCOS, especially those with severe obesity and insulin resistance.

High doses of norethindrone acetate in rats caused various organ changes but didn't significantly increase tumor rates.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

IL-2 treatment causes skin eruptions and other reversible side effects, and may play a role in psoriasis.

Using two drugs together, Flutamide and 4-MA, is more effective for blocking male hormones than using each one alone.

Mitoxantrone with a corticosteroid helps manage symptoms for some advanced prostate cancer patients but doesn't extend life.

Medroxyprogesterone acetate iontophoresis safely and effectively reduces facial hair growth in women.

The use of Diane-35 and its generics significantly decreased in the Netherlands.

Brepocitinib 30mg is most effective for moderate-to-severe alopecia areata, but ritlecitinib 50mg may offer a better balance of safety and effectiveness.

Both VEPA and ML-Y1 treatments are not effective enough for elderly non-Hodgkin's lymphoma patients.

Two non-steroidal antiandrogens, RU 58841 and RU 56187, form a common metabolite at different rates, which may influence their effects; RU 56187 could be used for prostate cancer treatment and RU 58841 for acne treatment.

Lovastatin doesn't improve lower urinary tract symptoms treatment.

A man's relapsed leprosy was successfully treated with the antibiotic sparfloxacin.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

Flibanserin's effectiveness for low sexual desire in premenopausal women may vary based on hormone levels, with normal hormone levels showing better responses.

Certain hormone medications can treat symptoms like acne and unwanted hair, regulate periods, and prevent pregnancy in women and teenage girls.

Testosterone therapy can improve sexual satisfaction and mood in surgically menopausal women when used with estrogen, but its long-term safety and effects on naturally menopausal and premenopausal women are unclear.

Teriflunomide is effective and generally safe for treating relapsing multiple sclerosis, reducing relapse rates and disability progression.

Ovulation inhibitors effectively treat menstrual issues and improve fertility but can have side effects.

Flutamide and finasteride reduced sex hormones in pregnant hyenas, but increased them in males.

Immunotherapy for cancer caused a patient to develop a condition affecting hormone production, requiring ongoing hormone replacement therapy.

The FDA did not approve a testosterone drug because of safety concerns.

Prostaglandin F2alpha and related compounds can increase hair growth and darken hair in mice.

Dutasteride effectively treats enlarged prostate with manageable side effects.